These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 11972394

  • 1. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

  • 2. What we know about low-level hCG: definition, classification and management.
    Kohorn EI.
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [Abstract] [Full Text] [Related]

  • 3. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 5. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N.
    Akush Ginekol (Sofiia); 1989 Jul; 28(2):15-9. PubMed ID: 2548413
    [Abstract] [Full Text] [Related]

  • 6. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY, Wong LC.
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 8. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA, Hussa RO.
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [Abstract] [Full Text] [Related]

  • 12. Inappropriate management of women with persistent low hCG results.
    Cole LA, Khanlian SA.
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [Abstract] [Full Text] [Related]

  • 13. [Persistent low levels of human chorionic gonadotropin in the serum: investigation and management].
    Faranesh R, Ben-David Y.
    Harefuah; 2009 Feb; 148(2):101-3, 139. PubMed ID: 19627038
    [Abstract] [Full Text] [Related]

  • 14. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 15. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 16. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA, Butler S.
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [Abstract] [Full Text] [Related]

  • 17. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 18. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 19. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
    Shimizu T, Matsuura S, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
    [Abstract] [Full Text] [Related]

  • 20. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY, Cole LA, Kardana A.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug; 29(8):475-7, 510-1. PubMed ID: 7835119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.